These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25583284)

  • 1. Myeloid sarcoma of the breast misdiagnosed as poorly differentiated mammary carcinoma with lobular features.
    Stewart RL; Dell CM; Samayoa L
    Breast J; 2015; 21(2):192-3. PubMed ID: 25583284
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
    Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
    Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
    Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Lobular Carcinoma With Extensive Clear Cells: A Pitfall in Diagnosis.
    Kavesh MH; Sanchez D; Asirvatham JR
    Int J Surg Pathol; 2020 Apr; 28(2):169-172. PubMed ID: 31619100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups.
    Ni YB; Tsang JY; Chan SK; Tse GM
    Histopathology; 2015 Jul; 67(1):96-105. PubMed ID: 25425335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer.
    Wang X; Zhong W; Bu J; Li Y; Li R; Nie R; Xiao C; Ma K; Huang X; Li Y
    Mol Carcinog; 2019 May; 58(5):674-685. PubMed ID: 30604894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct clinical and prognostic features of invasive lobular breast cancer.
    Petrausch U; Pestalozzi BC
    Breast Dis; 2008-2009; 30():39-44. PubMed ID: 19850994
    [No Abstract]   [Full Text] [Related]  

  • 9. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
    Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
    Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous unilateral infiltrating ductal and lobular breast carcinoma.
    Kaur S; Rahmat K; Chandran PA; Alli K; Aziz YF
    Singapore Med J; 2012 Nov; 53(11):e240-3. PubMed ID: 23192514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration cytology of pleomorphic lobular carcinoma of the breast. Duct carcinoma as a diagnostic pitfall.
    Dabbs DJ; Grenko RT; Silverman JF
    Acta Cytol; 1994; 38(6):923-6. PubMed ID: 7992580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic challenge of lobular carcinoma on aspiration cytology.
    Joshi A; Kumar N; Verma K
    Diagn Cytopathol; 1998 Mar; 18(3):179-83. PubMed ID: 9523134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picture Quiz. Breast imaging.
    Britton PD
    BMJ; 2008 Sep; 337():a1313. PubMed ID: 18799535
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to correspondence on 'low concordance of biomarkers in histopathological and cytological material from breast cancer'.
    Stålhammar G; Hartman J
    Histopathology; 2015 Apr; 66(5):756-8. PubMed ID: 25040089
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
    Sharma SD; Barry M; O'Reilly EA; Kell MR
    Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer.
    Schmitt F; Vielh P
    Histopathology; 2015 Jan; 66(2):314-5. PubMed ID: 24750212
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular analysis of breast sentinel lymph nodes.
    Blumencranz PW; Pieretti M; Allen KG; Blumencranz LE
    Surg Oncol Clin N Am; 2011 Jul; 20(3):467-85, viii. PubMed ID: 21640916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
    Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance mammography--open questions].
    Kessler M; Sittek H; Reiser M
    Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):M107-15. PubMed ID: 8974887
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.
    de Deus Moura R; Wludarski SC; Carvalho FM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):1-12. PubMed ID: 22595945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.